- Indication and interpretation of SARS-CoV-2 antibody diagnostics
- IP-10 – A new marker to detect cellular immune activation
- TH1/TH2 cytokine balance
- Tumours - Immunological laboratory testing in patients with tumours
- Determination of immunocompetence using the lymphocyte transformation test (LTT Immune Function)
- Cytomegalovirus (CMV) DNA determination using quantitative PCR
- Laboratory monitoring of immunostimulatory therapies with LTT immunostimulation
- Deficiency of Mannose-binding lectin (MBL) as a cause of impaired pathogen defence